Published in Int J Environ Res Public Health on December 22, 2015
Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy. EMBO Mol Med (2016) 0.75
Progression inference for somatic mutations in cancer. Heliyon (2017) 0.75
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
Cancer. p53, guardian of the genome. Nature (1992) 16.36
Mutations in the p53 gene occur in diverse human tumour types. Nature (1989) 13.62
Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol Cell Biol (2000) 9.21
Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell (1990) 6.37
Nanomechanical analysis of cells from cancer patients. Nat Nanotechnol (2007) 5.99
When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer (2009) 5.86
Mutant p53: one name, many proteins. Genes Dev (2012) 4.33
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell (2012) 4.09
Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell (2014) 3.68
Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines. Cancer Res (2011) 2.32
Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis. Cell Death Differ (2013) 1.77
The rebel angel: mutant p53 as the driving oncogene in breast cancer. Carcinogenesis (2012) 1.67
Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci U S A (1991) 1.65
Links between mutant p53 and genomic instability. J Cell Biochem (2012) 1.41
A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation. Breast Cancer Res (2011) 1.16
Paxillin mediates sensing of physical cues and regulates directional cell motility by controlling lamellipodia positioning. PLoS One (2011) 1.06
Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study. Cancer Epidemiol Biomarkers Prev (2015) 0.96
Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells. Biomed Res (2010) 0.92
Growth of lung cancer cells in three-dimensional microenvironments reveals key features of tumor malignancy. Integr Biol (Camb) (2011) 0.91
p53 binds to a constitutively nucleosome free region of the mdm2 gene. Oncogene (1998) 0.90
Label-free cancer cell detection with impedimetric transducers. Anal Chem (2009) 0.88
Impedimetric detection of mutant p53 biomarker-driven metastatic breast cancers under hyposmotic pressure. PLoS One (2014) 0.84
Proteome-wide analysis of mutant p53 targets in breast cancer identifies new levels of gain-of-function that influence PARP, PCNA, and MCM4. Proc Natl Acad Sci U S A (2015) 0.84
Triple-negative breast cancer: investigating potential molecular therapeutic target. Expert Opin Ther Targets (2014) 0.80